FDA approves new generic abortion pill Mifepristone; All you need to know
The US FDA has approved a new generic version of mifepristone, the abortion pill, from Evita Solutions. This second generic aims to boost competition, reduce costs, and broaden access to medication-based terminations. Used with misoprostol, it's effective up to 10 weeks of pregnancy, though it still adheres to strict regulatory conditions and carries known risks.
The US FDA has approved a new generic version of mifepristone, the abortion pill, from Evita Solutions. This second generic aims to boost competition, reduce costs, and broaden access to medication-based terminations. Used with misoprostol, it's effective up to 10 weeks of pregnancy, though it still adheres to strict regulatory conditions and carries known risks.
